Fifth Third Bancorp
LOXO

Fifth Third Bancorp’s Loxo Oncology, Inc LOXO Stock Holding History

Fifth Third Bancorp’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-29
Closed -$5K – 2403
2018
Q3 		$5K Sell
29
-25
-46% -$4.2K ﹤0.01% 2005
2018
Q2 		$9K Hold
54
– – ﹤0.01% 1933
2018
Q1 		$6K Hold
54
– – ﹤0.01% 2041
2017
Q4 		$5K Sell
54
-186
-78% -$15.5K ﹤0.01% 2020
2017
Q3 		$22K Buy
+240
New +$18.6K ﹤0.01% 1566

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's LOXO Position: Q4 2018 in Review

Fifth Third Bancorp sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 29 shares — an estimated $5K sold.

Fifth Third Bancorp first reported a position in LOXO in Q3 2017 and held it in 5 quarters. The position peaked at $22K in Q3 2017. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Fifth Third Bancorp reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Fifth Third Bancorp sold 29 Loxo Oncology, Inc shares in Q4 2018, an estimated $5K.
  • Fifth Third Bancorp first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 5 quarters.
  • Fifth Third Bancorp's Loxo Oncology, Inc position peaked at $22K in Q3 2017.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Fifth Third Bancorp's 13F filing for Q4 2018, filed 14 Feb 2019.